← Back to Search

Cognitive Behavioral Therapy

STAIR/NT for Post-Traumatic Stress Disorder

N/A
Waitlist Available
Led By Marylene Cloitre, PhD
Research Sponsored by Palo Alto Veterans Institute for Research
Eligibility Criteria Checklist
Specific guidelines that determine who can or cannot participate in a clinical trial
Must have
Be older than 18 years old
Timeline
Screening 3 weeks
Treatment Varies
Follow Up baseline, 12, 28, 36, 48 weeks
Awards & highlights

Study Summary

Researchers hope to learn whether a flexibly applied cognitive behavioral treatment for Post-Traumatic Stress Disorder (PTSD) is more effective than the psychotherapy usually provided in the clinic (called Treatment as Usual or TAU). Primary Hypothesis: STAIR/NT will be superior to TAU in improving PTSD symptoms at 28, 36 and 48 weeks post-randomization

Eligible Conditions
  • Post-Traumatic Stress Disorder

Timeline

Screening ~ 3 weeks
Treatment ~ Varies
Follow Up ~baseline, 12, 28, 36, 48 weeks
This trial's timeline: 3 weeks for screening, Varies for treatment, and baseline, 12, 28, 36, 48 weeks for reporting.

Treatment Details

Study Objectives

Outcome measures can provide a clearer picture of what you can expect from a treatment.
Primary outcome measures
Clinician Assessed PTSD Symptom Severity
PTSD Diagnosis
Secondary outcome measures
Emotion Regulation Problems
Interpersonal problems
Psychosocial Functioning

Trial Design

2Treatment groups
Experimental Treatment
Group I: Treatment as Usual (TAU)Experimental Treatment1 Intervention
Patients will receive Treatment as Usual (TAU)
Group II: STAIR/NTExperimental Treatment1 Intervention
Patients will receive STAIR/NT treatment
Treatment
First Studied
Drug Approval Stage
How many patients have taken this drug
STAIR/NT treatment
2012
N/A
~210
Treatment as Usual (TAU)
2016
Completed Phase 4
~3620

Find a Location

Who is running the clinical trial?

Grady Health SystemOTHER
11 Previous Clinical Trials
7,438 Total Patients Enrolled
Nathan Kline Institute for Psychiatric ResearchOTHER
37 Previous Clinical Trials
2,618 Total Patients Enrolled
Georgetown UniversityOTHER
343 Previous Clinical Trials
136,292 Total Patients Enrolled

Frequently Asked Questions

~16 spots leftby Apr 2025